“Atherosclerosis: Turn back time”

On the request of AstraZeneca, PR-Premier has organized and held the press conference “Atherosclerosis: Turn back time”, conducted in Russian News & Information Agency “NOVOSTI”.

Rafael Oganov, M.D., Professor Cardiologist, Academician of Russian Academy of Medical Sciences, honoured worker of science of the Russian Federation, chief research officer of Myasnikov Institute of Clinical Cardiology, told journalists about the current situation concerning the atherosclerosis incidence in Russia, its course and main methods of its medication.

Statement by Vyacheslav Mareev, chief research officer of Myasnikov Institute of Clinical Cardiology, was dedicated to results of the ASTEROID Trial. During this trial it was determined that “Crestor” by pharmaceutical company AstraZeneca can turn back time, resolving atherosclerosis plaque. This fact has proved the possibility of regression of coronary atherosclerosis and offers great opportunities in its treatment. This event has aroused much interest in representatives of medical, popular and socio-political mass media.

Client: AstraZeneca